The Impact of Non-dopaminergic Medication on Quality of Life in Parkinson's Disease.

Oonk, Nicol G M; Movig, Kris L L; van der Palen, Job; Nijmeijer, Henk-Willem; van Kesteren, Mirjam E; Dorresteijn, Lucille D A

Oonk, Nicol G M; Movig, Kris L L; van der Palen, Job; Nijmeijer, Henk-Willem; van Kesteren, Mirjam E; Dorresteijn, Lucille D A.

Afiliação

Oonk NGM; Department of Neurology, Medisch Spectrum Twente, Enschede, The Netherlands. n.oonk@mst.nl.
Movig KLL; Department of Clinical Pharmacy, Medisch Spectrum Twente, Enschede, The Netherlands.
van der Palen J; Department of Epidemiology, Medisch Spectrum Twente, Enschede, The Netherlands.
Nijmeijer HW; Department of Research Methodology, Measurement, and Data Analysis, University of Twente, Enschede, The Netherlands.
van Kesteren ME; Department of Neurology, Ziekenhuis Groep Twente, Almelo, The Netherlands.
Dorresteijn LDA; Department of Neurology, Isala, Zwolle, The Netherlands.

Clin Drug Investig ; 41(9): 809-816, 2021 Sep.

Article em En | MEDLINE | ID: mdl-34374959

Assuntos

Doença de Parkinson; Qualidade de Vida; Estudos Transversais; Feminino; Humanos; Dor; Doença de Parkinson/tratamento farmacológico; Doença de Parkinson/epidemiologia; Inquéritos e Questionários

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Qualidade de Vida Tipo de estudo: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: Clin Drug Investig Assunto da revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Holanda

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google